Cart (0 Items)
Your cart is currently empty.
View ProductsCustomers success stories
-
Customers success storiesThe Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Thomas Meyer
At ProteoGenix, we are devoted to promoting innovative research and offering superior solutions that assist our clients in reaching their scientific objectives. Our client at the University of Naples and…
-
Hybridoma-based antibody development: Targeting Key Protein in Long QT Syndrome and Advancing Cardiac Research
At ProteoGenix, we are always ready to take on a challenge. Particularly when it involves helping you reach your objectives. Read More
-
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Membrane proteins are critical for cellular signaling and transport, making them prime targets for drug development in cardiovascular and inflammatory… Read More
-
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Advances in science often depend on the ability to develop accurate tools to accelerate research, diagnostics, and therapeutic applications. Monoclonal… Read More
-
Pioneering the Development of Therapeutic Antibodies for Alzheimer’s Disease
Neurodegenerative diseases such as Alzheimer’s are among the most complex and devastating disorders of our time, affecting millions worldwide. Identifying… Read More
-
A cross-reactive antibody unravels the unexpected trigger of an aggressive autoimmune disease
Researchers have recently discovered a new mechanism that explains the development of membranous nephropathy (MN), a rare autoimmune disorder. By… Read More
-
Can antibodies help us identify elusive single-point mutations and quickly determine the prognosis in complex disease landscapes?
Researchers have recently demonstrated that an oncogenic mutation (R110) in the immunoglobulin light-chain variable region (IGLV) is an important and… Read More